Is Keflex (Cephalexin) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin Safety During Pregnancy

Cephalexin is safe to use during pregnancy and is classified as FDA Pregnancy Category B, making it an appropriate first-line antibiotic choice when treatment is needed. 1

Evidence Supporting Safety

Cephalexin belongs to the cephalosporin class of antibiotics, which have extensive clinical experience supporting their safety during pregnancy. The FDA drug label specifically states:

  • Reproduction studies performed on mice and rats using oral doses of cephalexin monohydrate up to 1.5 times the maximum daily human dose revealed no harm to the fetus 1
  • Animal studies have consistently shown no teratogenic effects 1

Cephalexin and other cephalosporins are considered safe first-line alternatives for pregnant women, especially for those with non-anaphylactic penicillin allergies 2.

Pharmacokinetics During Pregnancy

Studies examining cephalexin pharmacokinetics in pregnancy have demonstrated:

  • Cephalexin effectively crosses the placental barrier and reaches adequate levels in amniotic fluid and cord serum to inhibit common pathogens involved in maternal-fetal infections 3
  • The drug reaches peak concentration in maternal serum approximately 1 hour after oral administration 3

Clinical Applications

Cephalexin is commonly used during pregnancy for several indications:

  • Urinary tract infections (UTIs), which are among the most common bacterial infections during pregnancy 4
  • Skin and soft tissue infections
  • Respiratory tract infections
  • Prophylaxis for recurrent UTIs during pregnancy (250 mg as a single postcoital dose) 5

A prospective study comparing oral cephalexin (500 mg every 6 hours) with intravenous cephalothin for treatment of acute pyelonephritis in pregnancy showed equivalent efficacy (91.4% vs 92.9% successful therapy), demonstrating cephalexin's effectiveness for serious infections during pregnancy 6.

Precautions and Monitoring

While cephalexin is considered safe, some precautions should be observed:

  • Monitor for gastrointestinal side effects (diarrhea, nausea, vomiting) 1
  • Be aware of potential allergic reactions, especially in patients with penicillin allergy history 1
  • The drug is excreted in breast milk, reaching maximum levels of 4 mcg/mL within 4 hours after a 500 mg dose, then gradually decreasing and disappearing after 8 hours 1
  • Caution should be exercised when administering cephalexin to nursing women, although it's generally considered compatible with breastfeeding 1

Comparison with Other Antibiotics

When considering antibiotic choices during pregnancy:

  • Penicillins and cephalosporins have decades of clinical experience documenting their safety for both mother and fetus 7
  • Cephalexin is preferred over antibiotics that should be avoided during pregnancy, such as:
    • Tetracyclines (risk of permanent tooth discoloration and bone growth inhibition) 2
    • Fluoroquinolones (potential cartilage damage) 2
    • Trimethoprim-sulfamethoxazole (risk of birth defects and kernicterus) 2
    • Aminoglycosides (risk of ototoxicity and nephrotoxicity) 2

Dosing Recommendations

Standard dosing for cephalexin during pregnancy follows general adult dosing guidelines:

  • 250-500 mg orally every 6 hours, depending on the severity of infection
  • For UTI prophylaxis: 250 mg as a single postcoital dose 5
  • Duration depends on the type and severity of infection

Conclusion

Based on extensive clinical experience and safety data, cephalexin is a safe and effective antibiotic choice during pregnancy. Its FDA Pregnancy Category B classification, favorable pharmacokinetic profile, and established efficacy for common infections make it an appropriate first-line option when antibiotic therapy is indicated during pregnancy.

References

Guideline

Antibiotic Use During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A study of the kinetics of cephapirin and cephalexin in pregnancy.

Current medical research and opinion, 1980

Research

Urinary tract infections during pregnancy.

The Annals of pharmacotherapy, 2004

Research

Effective prophylaxis for recurrent urinary tract infections during pregnancy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Research

Antibacterial agents in pregnancy.

Infectious disease clinics of North America, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.